Nadroparin
- Generic Name
- Nadroparin
- Brand Names
- Fraxiparine
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 1K5KDI46KZ
- Background
Nadroparin is a low molecular weight heparin (LMWH) which, when bound to antithrombin III (ATIII), accelerates the inactivation of factor II and factor Xa. Nadroparin halts the coagulation pathway by inhibiting the activation of thrombin (factor IIa) by factor Xa. The amplification of the fibrin clotting cascade is stopped once factors Xa and IIa are inactiv...
- Indication
Nadroparin is used for prophylaxis of thromboembolic disorders and general surgery in orthopedic surgery, treatment of deep vein thrombosis, prevention of clotting during hemodialysis and treatment of unstable angina and non-Q wave myocardial infarction.
- Associated Conditions
- Clotting, Deep Vein Thrombosis, Pulmonary Embolism, Unstable Angina Pectoris, Venous Thromboembolism, Non-q wave myocardial infarction, Thromboembolic phenomena
- Associated Therapies
- -
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
- Conditions
- Interventions
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT06319131
Nadroparin Pharmacokinetics in Different Stages of COVID-19
- Conditions
- Interventions
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Medical University of Lublin
- Target Recruit Count
- 43
- Registration Number
- NCT05621915
- Locations
- 🇵🇱
2nd Department of Anesthesiology and Critical Care, Medical University of Lublin, Lublin, Lubelskie, Poland
Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
- Conditions
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2024-04-18
- Target Recruit Count
- 224
- Registration Number
- NCT04067505
- Locations
- 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳Shanghai 5th People's Hospital, Shanghai, Shanghai, China
🇨🇳Zhongshan Hospital affiliated to Fudan University, Shanghai, Shanghai, China
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
- Conditions
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2024-04-18
- Target Recruit Count
- 200
- Registration Number
- NCT04066764
- Locations
- 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳Yantai Yuhuangding Hospital, Yantai, Shangdong, China
🇨🇳Shanghai 5th People's Hospital, Shanghai, Shanghai, China
Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events
- Conditions
- Interventions
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 280
- Registration Number
- NCT02987946
- Locations
- 🇳🇱
Leiden University Medical Centre, Leiden, Zuid Holland, Netherlands
LMWH Infusion as Anticoagulation for Home HD
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- Alice Ho Miu Ling Nethersole Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT02957877
- Locations
- 🇭🇰
Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong
Prophylaxis of Venous Thromboembolism After Bariatric Surgery
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Rijnstate Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT02295150
- Locations
- 🇳🇱
Rijnstate Hospital, Arnhem, Wagnerlaan 55, Netherlands
Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
- First Posted Date
- 2013-05-27
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- University Hospital, Martin
- Target Recruit Count
- 150
- Registration Number
- NCT01862978
- Locations
- 🇸🇰
Neurology Clinic Univeristy Hospital in Martin, Martin, Slovakia
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-09-09
- Last Posted Date
- 2018-06-07
- Lead Sponsor
- Martini Hospital Groningen
- Target Recruit Count
- 148
- Registration Number
- NCT01431456
- Locations
- 🇳🇱
Martini Ziekenhuis, Groningen, Netherlands
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
- Conditions
- Interventions
- First Posted Date
- 2010-12-28
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 362
- Registration Number
- NCT01267305
- Locations
- 🇨🇳
Zhongshan Hospital, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.